Las Vegas, NV -- (SBWIRE) -- 09/27/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: rue21, inc. (NASDAQ:RUE), Knight Transportation (NYSE:KNX), Ambarella Inc (NASDAQ:AMBA), Sarepta Therapeutics Inc (NASDAQ:SRPT)
rue21, inc. (NASDAQ:RUE) managed to keep its fall at -2.03% on above-normal volume of 2.77M shares. The stock settled at $39.66 after floating in a range of $39 to $40.10. Its latest price has reached market capitalization of $932.84 million. Its 52-week range has been $26.21 to $42.49. rue21, Inc. operates as a specialty retailer of junior girls and young men?s apparel and accessories in the United States.
Has RUE Found The Bottom and Ready To Move Up? Find Out Here
Knight Transportation (NYSE:KNX) traded up on a volume of 2.76 million, higher than its standard daily volume. Shares have gained 3.75% to $16.60. Over the last twelve months, the stock has gained 15.68% and faced a worst price of $13.74. Knight Transportation, Inc. (Knight) is a provider of multiple truckload transportation services, which generally involve the movement of full trailer or container loads of freight from origin to destination for a single customer.
For How Long KNX’s Gloss will Attract Investors? Find out via this report
Ambarella Inc (NASDAQ:AMBA) settled 2.15% higher/lower at $19.52 on above-normal volume of 2.71M shares during the last trading day. The stock has its 12-month high at $19.80 and 52-week low price was $5.55. It traded in a range of $18.83 to $19.80 during the last trading day. Ambarella, Inc. is a developer of semiconductor processing solutions for video that enable high-definition (HD), video capture, sharing and display.
Why Should Investors Buy AMBA After the Recent Fall? Just Go Here and Find Out
In the last trading session, Sarepta Therapeutics Inc (NASDAQ:SRPT) was up on high volume, trading at a volume of 2.70M versus its average daily volume of 2.03 million shares. At $46.52, the stock has attained market capitalization of 1.56 billion. Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases.
Will SRPT Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)